Hemex
-
Type of investor
Seed Investor -
Based in
Liestal BL -
Number of investments
6-10 -
Industry
biotech, healthcare IT, ICT, medtech, micro / nanoVisit website of
Hemex
Related News
29.04.2025 16:00
Annaida obtains undisclosed pre-series A funding
25.03.2024 16:34
CHF 14 million to fund hemotune’s clinical trials
15.12.2022 09:00
CHF 4 million for Bottneuro
17.11.2022 17:00
USD 5 million to speed ASPIVIX entry on European and US Markets
26.04.2022 12:00
CHF 7.25 million for a platform reducing the burden of sepsis
10.02.2021 16:45
HEMEX closes an oversubscribed Series C financing round
12.08.2020 17:00
Scailyte announces final closing of pre-series A financing
10.06.2020 08:45
Scailyte bags over 3 million Swiss Francs
09.04.2020 15:31
Annaida raises CHF1 million to improve In Vitro Fertilization
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
